Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Effectiveness of Therapy for Patients With Covid-19 Using Food Supplements Viusid + Asbrip

NCT04980534 is registered in ClinicalTrials.gov with Catalysis SL as lead sponsor.

NCT NCT04980534
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04980534 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Effectiveness of Therapy for Patients With Covid-19 Using Food Supplements Viusid + Asbrip
Lead sponsor
Catalysis SL
Phase
Not applicable
Overall status
Completed
Start date
January 8, 2021
Completion date
September 15, 2021
Enrollment
80 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19 pneumonia, covid-19 respiratory infection, covid19, infection, coronavirus, respiratory tract infections, sars-cov2 infection, viral infection